To assess the clinical relevance of TRAF4 nuclear translocation, we performed immunohistochemical staining (IHC) analyses on tissue microarrays derived from human breast cancer (Figure1A–C), colon cancer (Figure 1D–F), and glioma (Figure 1G–I). This evidence concerns the gene TRAF4 and central nervous system cancer.